Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
- 1 March 1996
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 726 (1-2), 115-124
- https://doi.org/10.1016/0021-9673(96)88660-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Synthesis of the 5-HT1D receptor agonist MK-0462 via a Pd-catalyzed coupling reactionTetrahedron Letters, 1994
- A rapid and specific assay, based on liquid chromatography—atmospheric pressure chemical ionization mass spectrometry, for the determination of MK-434 (a 5α-reductase inhibitor) and its metabolites in plasmaJournal of Pharmaceutical and Biomedical Analysis, 1994
- Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical Sciences, 1993
- Determination of L-654,066, a new 5α-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometryJournal of Mass Spectrometry, 1992
- Preclinical Studies on the Anti-Migraine Drug, SumatriptanEuropean Neurology, 1991
- 5-Hydroxytryptamine and Its Role in MigraineEuropean Neurology, 1991
- Development and validation of a liquid chromatographic-mass spectrometric assay for the determination of sumatriptan in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1989